Andrew R. Jassy, President and Chief Executive Officer of Amazon.com Inc. (NASDAQ:AMZN), disposed of 31,000 shares of the company's common stock on April 17, 2026. The shares were sold at $255.00 apiece, producing proceeds of $7,905,000.
The transaction was carried out directly by Jassy and executed in accordance with a Rule 10b5-1 trading plan he established on November 14, 2025. At the time of the sale, Amazon's share price was trading near its 52-week high of $258.60, following a reported 48% total return over the preceding year.
Following the April 17 sale, Jassy's direct ownership of Amazon common stock stands at 2,207,118 shares. In addition to his direct holdings, he retains indirect interests: 65,500 shares held in trust and 9,922.775 shares held indirectly through an Amazon.com 401(k) plan account.
Valuation and analyst context
InvestingPro's analysis, as reported, indicates that Amazon's stock appears fairly valued relative to its Fair Value estimate. The analysis also notes the availability of 13 additional ProTips and broader financial health scores through the platform's Pro Research Report.
Market commentary accompanying company developments shows several analyst moves tied to Amazon's business expansion. Roth/MKM reiterated a Buy rating with a $285 price target after Amazon expanded its partnership with Anthropic and committed an additional $5 billion, with plans for a further $20 billion investment. Cantor Fitzgerald raised its price target to $280, citing robust Amazon Web Services (AWS) growth driven by AI demand. Truist Securities maintained a Buy rating and emphasized the deepening AWS relationship with Anthropic, which is expected to support AI training and inference capabilities.
Company initiatives
In separate corporate activity, Amazon announced a logistics partnership with Swedish trucking firm Einride to deploy 75 electric heavy-duty trucks across five U.S. locations. That program is planned to include charging infrastructure and the use of Einride's Saga AI software for vehicle operations management.
Amazon has also introduced a weight management program through Amazon One Medical that integrates GLP-1 medications with primary care services. The rollout of that program has been reported to affect shares of Hims & Hers Health.
These developments - insider selling under a pre-established trading plan, analyst reactions, and operational initiatives spanning logistics, healthcare and AI partnerships - provide market participants with discrete data points about executive activity and corporate strategy. The sale by Amazon's chief executive, the ongoing investments in AI and cloud computing, and the logistics deployments are presented here without further extrapolation.